Millennium Management’s DiaMedica Therapeutics DMAC Stock Holding History

Millennium Management’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.95M	Sell	845,309 -90,283	-10%	-$555K	﹤0.01%	2823
2026 Q1	$6.33M	Buy	935,592 +167,032	+22%	+$1.32M	﹤0.01%	2678
2025 Q4	$6.12M	Sell	768,560 -418,749	-35%	-$3.13M	﹤0.01%	2788
2025 Q3	$8.16M	Buy	+1,187,309	New	+$6.44M	﹤0.01%	2598
2025 Q2	–	Sell	-336,880	Closed	-$1.28M	–	5946
2025 Q1	$1.28M	Buy	336,880 +252,051	+297%	+$1.44M	﹤0.01%	4164
2024 Q4	$461K	Buy	84,829 +51,139	+152%	+$241K	﹤0.01%	4815
2024 Q3	$141K	Buy	+33,690	New	+$124K	﹤0.01%	5525
2024 Q1	–	Sell	-28,845	Closed	-$81.9K	–	6253
2023 Q4	$81.9K	Buy	28,845 +173	+0.6%	+$428	﹤0.01%	5387
2023 Q3	$74K	Buy	+28,672	New	+$92.1K	﹤0.01%	5408
2022 Q1	–	Sell	-22,249	Closed	-$83K	–	7012
2021 Q4	$83K	Buy	+22,249	New	+$87.4K	﹤0.01%	6325
2021 Q3	–	Sell	-20,690	Closed	-$92K	–	6865
2021 Q2	$92K	Sell	20,690 -49,591	-71%	-$407K	﹤0.01%	6250
2021 Q1	$643K	Buy	70,281 +29,420	+72%	+$275K	﹤0.01%	4612
2020 Q4	$414K	Buy	+40,861	New	+$224K	﹤0.01%	4345
2020 Q2	–	Sell	-10,872	Closed	-$30K	–	4236
2020 Q1	$30K	Sell	10,872 -22,091	-67%	-$91.3K	﹤0.01%	3711
2019 Q4	$160K	Sell	32,963 -37,956	-54%	-$118K	﹤0.01%	3926
2019 Q3	$145K	Sell	70,919 -28,421	-29%	-$91.9K	﹤0.01%	3881
2019 Q2	$493K	Buy	+99,340	New	+$344K	﹤0.01%	3245

Other funds holding DMAC

CLG

Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Millennium Management's DMAC Position: Q2 2026 in Review

Millennium Management reduced its DiaMedica Therapeutics (DMAC) stake by 9.6% in Q2 2026, selling an estimated $555K and leaving 845,309 shares worth $5.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2823.

Millennium Management first reported a position in DMAC in Q2 2019 and has held it in 17 quarters since. The position peaked at $8.16M in Q3 2025. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

Millennium Management held 845,309 shares of DiaMedica Therapeutics worth $5.95M as of Q2 2026.
Millennium Management sold 90,283 DiaMedica Therapeutics shares in Q2 2026, an estimated $555K.
DiaMedica Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #2823 holding.
Millennium Management first reported a position in DiaMedica Therapeutics in Q2 2019 and has held it in 17 quarters since.
Millennium Management's DiaMedica Therapeutics position peaked at $8.16M in Q3 2025.
89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.